FMC stock: Deutsche Bank keeps EUR 40.00 target for FMC stock

Published on 10/19/2026 at 16:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter results arrive on November 3, 2026. FMC stock costs EUR 39.07 on October 19, 2026, down 1.19 percent versus the Xetra close.

Analyst target and reporting date

According to TipRanks on October 19, 2026, Deutsche Bank kept a Hold rating and EUR 40.00 target.
Fresenius Medical Care lists November 3, 2026, for its third-quarter results.
FMC stock costs EUR 39.07 at Lang & Schwarz on October 19, 2026 at 4:10 p.m. CEST, 1.19 percent below the Xetra close of October 16, 2026.
FMC has a P/E ratio of 11.76 and a market capitalization of EUR 10.4 billion.

Pop-Art-Comic einer stilisierten Niere mit blauen Wassertropfen und Schriftzug CARE im Lichtenstein-Stil — Eine lebhafte Pop-Art-Illustration einer stilisierten Niere mit blauen Wassertropfen und der Aufschrift 'CARE' im Comic-Sprechblasen-Stil – eine kreative Interpretation des Kernthemas von Fresenius Medical Care AG (ISIN DE0005785802), Illustration mit AI erstellt.

Fresenius Medical Care (DE0005785802) carries a Deutsche Bank Hold rating and a EUR 40.00 target, 2.38 percent above the EUR 39.07 Lang & Schwarz price on October 19, 2026, according to TipRanks.
At 4:10 p.m. CEST, the stock stood 1.19 percent below the Xetra close of October 16, 2026, at EUR 39.54.

Results arrive November 3, 2026

The company lists November 3, 2026, for its third-quarter results. The investor calendar also identifies November 6, 2026, for the quarterly financial report, making the reporting week important for the next assessment of operating trends, cash generation and management commentary.

Price sits below the yearly midpoint

The Xetra quote was EUR 39.54 on October 16, 2026. Against the current Lang & Schwarz price of EUR 39.07 on October 19, the stock is 17.82 percent below its 52-week high of EUR 47.54 and 13.02 percent above its 52-week low of EUR 34.57. Trading volume stood at 233,769 shares, versus an average of 843,340 shares, a 72.28 percent lower level.

Valuation and reporting calendar

Fresenius Medical Care had a market capitalization of EUR 10.4 billion and a P/E ratio of 11.76 as of October 19, 2026. The Deutsche Bank target of EUR 40.00 is 2.38 percent above the Lang & Schwarz price, while the next company date is November 3, 2026.

Comparison with peers

FMC: minus 1.19 percent, P/E 11.76, market capitalization EUR 10.4 billion

DaVita (NYSE, USD): plus 0.33 percent, P/E 16.49, market capitalization USD 12.0 billion

Globus Medical (NYSE, USD): minus 0.66 percent, P/E 19.61, market capitalization USD 10.2 billion

FMC stock at Lang & Schwarz

The euro quote places FMC below its October 16 Xetra close while the EUR 40.00 analyst target sits above the latest price. The next scheduled report on November 3 provides the nearest dated checkpoint for the valuation and operating picture.

FMC stock was trading at EUR 39.07 at Lang & Schwarz on October 19, 2026 at 4:10 p.m. CEST, down 1.19 percent versus the Xetra close of October 16, 2026 at EUR 39.54. The further course of trading is shown by the continuously updated real-time quote of FMC stock.